Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
ENTREMED (NQ: ENMD)
1.850 USD  -0.020 (-1.07%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 17, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about ENTREMED
 
EntreMed Reports First Quarter 2013 Financial Results
May 15, 2013
from PR Newswire
Patent Issued In China For EntreMed's Lead Drug Candidate ENMD-2076
May 06, 2013
Patent Covers Composition of Matter and Uses for Various Cancers Read More
from PR Newswire
Patent Issued In U.S. For EntreMed's 2ME2 In Rheumatoid Diseases
May 03, 2013
from PR Newswire
EntreMed Announces Changes to Board of Directors and CEO Appointment
April 05, 2013
from PR Newswire
EntreMed Reports Fourth Quarter And Year-End 2012 Financial Results And Business Outlook For 2013
March 21, 2013
from PR Newswire
Burrill Securities Acts as Exclusive Placement Agent for EntreMed $10.7 Million Registered Direct
March 01, 2013
from Marketwired News Releases
EntreMed To Raise $10.7 Million In Registered Direct Offering
March 01, 2013
from PR Newswire
Sharp Increase in FDA Drug Approvals a Major Factor in Biotech Industry's Success
February 26, 2013
RDInvesting Provides Stocks Research on XOMA and EntreMed Read More
from Marketwired News Releases
Perfect Trade Setups, How to Play ACRX, ENMD, NLY and WPI
January 23, 2013
from Marketwired News Releases
EntreMed Announces Initiation Of Phase 2 Trial In Advanced/Metastatic Soft Tissue Sarcoma
January 23, 2013
from PR Newswire
EntreMed Files New Drug Clinical Trial Application For ENMD-2076 With China SFDA To Advance Global Development Strategy
January 07, 2013
from PR Newswire
EntreMed Announces Initiation Of Second Site For Phase 2 Trial In Triple-Negative Breast Cancer
January 04, 2013
from PR Newswire
The Real Story Behind ENMD, SPMD, TIGR and TGS
December 27, 2012
from Marketwired News Releases
PNAS Publishes Preclinical Results of EntreMed's 2ME2 for Multiple Sclerosis
December 04, 2012
from PR Newswire
Free Research Reports on CLSN, ENMD, LPR and P Issued by the Bedford Report
November 27, 2012
The Following Is an Investment Opinion Being Issued by the Equity News Circuit Read More
from Marketwired News Releases
Improving Trend in FDA First Cycle Review Approvals a Major Factor for Biotech Industry's Success in 2012
November 27, 2012
Five Star Equities Provides Stock Research on Alexza Pharmaceuticals and EntreMed Read More
from Marketwired News Releases
EntreMed Announces Publication Of Preclinical Results For ENMD-2076 In Triple-negative Breast Cancer
November 26, 2012
Predictive biomarkers of sensitivity to ENMD-2076 published in Clinical Cancer Research Read More
from PR Newswire
EntreMed Reports Third Quarter 2012 Financial Results
November 14, 2012
from PR Newswire
Dana-Farber Cancer Institute's Ursula A. Matulonis, MD Article on EntreMed's ENMD-2076 Published in the European Journal of Cancer
September 06, 2012
from PR Newswire
EntreMed Reports Second Quarter 2012 Financial Results
August 14, 2012
from PR Newswire
EntreMed Announces Initiation Of Phase 2 Trial In Triple-negative Breast Cancer
July 25, 2012
from PR Newswire
EntreMed Reports First Quarter 2012 Financial Results
May 15, 2012
from PR Newswire
EntreMed Regains Nasdaq Compliance With Shareholders' Equity Listing Requirement
May 10, 2012
from PR Newswire
EntreMed Appoints Interim CEO
April 03, 2012
Experienced Drug Developer Executive Joins Company to Execute on Global Drug Development Plan Read More
from PR Newswire
EntreMed Reports Fourth Quarter and Year-End 2011 Financial Results
March 09, 2012
from PR Newswire
EntreMed Initiates Plans for China Office
March 05, 2012
from PR Newswire
EntreMed Completes Strategic Financing
February 06, 2012
from PR Newswire
Biotech Leaders Wei-Wu He, Ph.D and Tak W. Mak, Ph.D Join EntreMed's Board of Directors
February 06, 2012
from PR Newswire
ENMD and UNVC are the Daily Market Movers for February 3rd from OTCPicks.com
February 03, 2012
from EmailWire.Com Press Releases
MITI, ENMD and IRSN are the Stocks to Watch for January 27th from OTCPicks.com
January 27, 2012
from EmailWire.Com Press Releases
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here